Market Value476,431,140
Total Holdings61
File Date2023-02-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RXDX / Prometheus Biosciences Inc
KYMR / Kymera Therapeutics, Inc.
NTRA / Natera, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
CINC / CinCor Pharma Inc
FMTX / Forma Therapeutics Holdings Inc
HZNP / Horizon Therapeutics Plc
DSGN / Design Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
TGTX / TG Therapeutics, Inc.
BSX / Boston Scientific Corporation
HRTX / Heron Therapeutics, Inc.
UHS / Universal Health Services, Inc.
ALKS / Alkermes plc
ARCT / Arcturus Therapeutics Holdings Inc.
LFST / LifeStance Health Group, Inc.
CNC / Centene Corporation
KROS / Keros Therapeutics, Inc.
CRSP / CRISPR Therapeutics AG
INSP / Inspire Medical Systems, Inc.
ITOS / iTeos Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
AGIO / Agios Pharmaceuticals, Inc.
COO / The Cooper Companies, Inc.
KRYS / Krystal Biotech, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
MGTA / Magenta Therapeutics Inc
SIBN / SI-BONE, Inc.
DVA / DaVita Inc.
AKRO / Akero Therapeutics, Inc.
MCK / McKesson Corporation
CAH / Cardinal Health, Inc.
CYTK / Cytokinetics, Incorporated
QURE / uniQure N.V.
CYTK / Cytokinetics, Incorporated Call
VKTX / Viking Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
THC / Tenet Healthcare Corporation
HCA / HCA Healthcare, Inc.
BAX / Baxter International Inc.
PRGO / Perrigo Company plc
EXAS / Exact Sciences Corporation
LLY / Eli Lilly and Company
UNH / UnitedHealth Group Incorporated
GOSS / Gossamer Bio, Inc.
MRTX / Mirati Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
AMED / Amedisys, Inc.
ILMN / Illumina, Inc.
PRVA / Privia Health Group, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
SNY / Sanofi - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
TFX / Teleflex Incorporated
SAGE / Sage Therapeutics, Inc.
WBA / Walgreens Boots Alliance, Inc.
GH / Guardant Health, Inc.
DOCS / Doximity, Inc.
/ VENTYX BIOSCIENCES INC
KDNY / Chinook Therapeutics Inc
RAPT / RAPT Therapeutics, Inc.
ISEE / IVERIC bio Inc
DHR / Danaher Corporation
FOLD / Amicus Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
MDGL / Madrigal Pharmaceuticals, Inc. Put
CVS / CVS Health Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ZNTL / Zentalis Pharmaceuticals, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
PEN / Penumbra, Inc.
CI / The Cigna Group
KURA / Kura Oncology, Inc.
PODD / Insulet Corporation
DGX / Quest Diagnostics Incorporated
DNLI / Denali Therapeutics Inc.
IRTC / iRhythm Technologies, Inc.
BPMC / Blueprint Medicines Corporation
RVNC / Revance Therapeutics, Inc.
NVST / Envista Holdings Corporation
FGEN / FibroGen, Inc.
MRNA / Moderna, Inc.
REPL / Replimune Group, Inc.
GILD / Gilead Sciences, Inc.
NVRO / Nevro Corp.
SUPN / Supernus Pharmaceuticals, Inc.
ABBV / AbbVie Inc.
MRK / Merck & Co., Inc.
RLAY / Relay Therapeutics, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
ISRG / Intuitive Surgical, Inc.
ELV / Elevance Health, Inc.
APLS / Apellis Pharmaceuticals, Inc.